Your browser doesn't support javascript.
loading
Adjuvant treatment of endometrial cancer today.
Aoki, Yoichi; Kanao, Hiroyuki; Wang, Xipeng; Yunokawa, Mayu; Omatsu, Kohei; Fusegi, Atsushi; Takeshima, Nobuhiro.
Afiliação
  • Aoki Y; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Kanao H; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Wang X; Department of Gynecology and Obstetrics, Xin Hua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yunokawa M; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Omatsu K; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Fusegi A; Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Takeshima N; Department of Perinatal and Women's Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Jpn J Clin Oncol ; 50(7): 753-765, 2020 Jul 09.
Article em En | MEDLINE | ID: mdl-32463094
Endometrial cancer frequently occurs in post-menopausal women, and the endometrium is a well-known site of cancer affecting women. Endometrial cancer is found with genital bleeding and often at an early stage. However, there are some risks of recurrence after hysterectomy. As a medical treatment after the diagnosis of endometrial cancer, appropriate adjuvant therapy is considered to lead to a decrease in the rate of recurrence and improvement of prognosis according to the determination of the cancer stage from the surgical and histopathological results. In this review, we describe post-operative adjuvant therapy administered for endometrial cancer and advanced disease, focusing on chemotherapy, radiation therapy and the combination of both. These treatments are divided according to the risk of recurrence as based primarily on the reported evidence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Quimioterapia Adjuvante Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Quimioterapia Adjuvante Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão